Sort   by:  
 Page size 
Unknown3-O-acetylrubiarbonol B preferentially targets EGFR and MET over rubiarbonol B to inhibit NSCLC cell growth.
Not available
S-EPMC12416685 | biostudies-literature
UnknownDeoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells.
Not available
S-EPMC11379681 | biostudies-literature
UnknownPrognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy.
Not available
S-EPMC5532319 | biostudies-literature
UnknownClinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET.
Not available
S-EPMC6942396 | biostudies-literature
UnknownMonoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models.
Not available
S-EPMC10104896 | biostudies-literature
UnknownSurvival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and Parkinsonism.
Not available
S-EPMC9025342 | biostudies-literature
UnknownDiverse Clinical Phenotypes of Neuronal Intranuclear Inclusion Disease in South Korea.
Not available
S-EPMC12303689 | biostudies-literature
UnknownIdentifying novel genetic variants for brain amyloid deposition: a genome-wide association study in the Korean population.
Not available
S-EPMC8215820 | biostudies-literature
UnknownGenetic Screening in Korean Patients with Frontotemporal Dementia Syndrome.
Not available
S-EPMC9661354 | biostudies-literature
UnknownEnhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19.
Not available
S-EPMC8450316 | biostudies-literature
Sort   by:  
 Page size